QLT, Inc. (NASDAQ: QLTI) announced that QLT USA, its wholly-owned subsidiary, has entered into an asset purchase agreement with Allergan (NYSE: AGN) to fully divest QLT’s worldwide rights to Aczone®, a prescription topical medicine approved in the United States and Canada for the treatment of acne vulgaris. Under the terms of the agreement, QLT will [...]

• 413http://clsdf.com/2008/06/qlt-reaches-140m-agreement-with-allergan/QLT+Reaches+%24140M+Agreement+with+Allergan2008-06-11+03%3A08%3A00admin

Otsuka Pharmaceutical entered into a collaboration agreement to use SomaLogic’s proprietary aptamer technology to discover and develop novel diagnostic products and to design research tools that will enhance Otsuka’s discovery and development efforts. SomaLogic will receive research funding and will be entitled to receive a royalty on any marketed products developed as a result of [...]

• 412http://clsdf.com/2008/06/somalogic-otsuka-early-detection-diagnosis/SomaLogic+%2B+Otsuka+%3D+Early+Detection+%2B+Diagnosis2008-06-11+03%3A03%3A00admin

Colorado life scientist’s and life science companies have recently been appearing left and right in the national spotlight, first in Popular Science then in Newsweek and now…Did you happen to catch 60 Minutes this past Sunday night? If not, the segment on Howard Hughes and how the Howard Hughes Medical Institute came to fruition featured [...]

• 411http://clsdf.com/2008/06/thom-cech-on-60-minutes/Thom+Cech+on+60+Minutes2008-06-10+14%3A49%3A00admin